TS
REGN icon

Tamar Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Tamar Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2M Sell
35,199
-5,257
-13% -$4.02M 2.91% 12
2025
Q4 		$31.2M Buy
40,456
+8,190
+25% +$5.56M 3.3% 8
2025
Q3 		$18.1M Buy
32,266
+1,885
+6% +$1.07M 2.06% 23
2025
Q2 		$15.9M Buy
30,381
+2,247
+8% +$1.25M 1.93% 23
2025
Q1 		$17.8M Buy
28,134
+7,733
+38% +$5.32M 2.42% 21
2024
Q4 		$14.5M Buy
20,401
+4,909
+32% +$4.12M 2% 25
2024
Q3 		$16.3M Buy
15,492
+2,211
+17% +$2.46M 2.29% 24
2024
Q2 		$14M Sell
13,281
-731
-5% -$709K 2.26% 24
2024
Q1 		$13.5M Sell
14,012
-216
-2% -$205K 2.28% 21
2023
Q4 		$12.5M Buy
14,228
+1,354
+11% +$1.12M 2.45% 19
2023
Q3 		$10.6M Sell
12,874
-166
-1% -$130K 2.55% 15
2023
Q2 		$9.37M Buy
13,040
+1,570
+14% +$1.21M 2.3% 19
2023
Q1 		$9.42M Sell
11,470
-1,180
-9% -$890K 2.71% 14
2022
Q4 		$9.13M Sell
12,650
-116
-0.9% -$85.6K 2.9% 17
2022
Q3 		$8.79M Buy
12,766
+486
+4% +$306K 2.81% 12
2022
Q2 		$7.26M Buy
12,280
+319
+3% +$207K 2.38% 18
2022
Q1 		$8.35M Buy
11,961
+1,358
+13% +$859K 2.33% 18
2021
Q4 		$6.7M Sell
10,603
-152
-1% -$93.5K 1.97% 24
2021
Q3 		$6.51M Sell
10,755
-76
-0.7% -$47.2K 2.35% 20
2021
Q2 		$6.05M Buy
10,831
+689
+7% +$349K 2.33% 19
2021
Q1 		$4.8M Buy
10,142
+1,904
+23% +$927K 1.86% 25
2020
Q4 		$3.98M Buy
8,238
+667
+9% +$360K 2.26% 19
2020
Q3 		$4.24M Buy
7,571
+472
+7% +$286K 2.63% 15
2020
Q2 		$4.43M Buy
+7,099
New +$4.03M 3.53% 8

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Tamar Securities's REGN Position: Q1 2026 in Review

Tamar Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 13% in Q1 2026, selling an estimated $4.02M and leaving 35,199 shares worth $27.2M. The position accounts for 2.91% of the portfolio, ranked #12.

Tamar Securities first reported a position in REGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $31.2M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Tamar Securities held 35,199 shares of Regeneron Pharmaceuticals worth $27.2M as of Q1 2026.
  • Tamar Securities sold 5,257 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $4.02M.
  • Regeneron Pharmaceuticals made up 2.91% of Tamar Securities's portfolio in Q1 2026, its #12 holding.
  • Tamar Securities first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Tamar Securities's Regeneron Pharmaceuticals position peaked at $31.2M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Tamar Securities's 13F filing for Q1 2026, filed 14 May 2026.